These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 15914298)
1. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy. Karch R; Neumann F; Ullrich R; Neumüller J; Podesser BK; Neumann M; Schreiner W Cardiovasc Pathol; 2005; 14(3):135-44. PubMed ID: 15914298 [TBL] [Abstract][Full Text] [Related]
2. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy. Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy. Dashkevich A; Bloch W; Antonyan A; Goebel H; Fries JU; Schlensak C; Beyersdorf F; Geissler HJ Lymphology; 2010 Sep; 43(3):110-7. PubMed ID: 21226413 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Noutsias M; Pauschinger M; Schultheiss H; K hl U Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194 [TBL] [Abstract][Full Text] [Related]
5. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods. Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331 [TBL] [Abstract][Full Text] [Related]
7. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Theiss HD; David R; Engelmann MG; Barth A; Schotten K; Naebauer M; Reichart B; Steinbeck G; Franz WM Eur Heart J; 2007 May; 28(10):1258-64. PubMed ID: 17395679 [TBL] [Abstract][Full Text] [Related]
8. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy. Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256 [TBL] [Abstract][Full Text] [Related]
9. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502 [TBL] [Abstract][Full Text] [Related]
10. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. Tsagalou EP; Anastasiou-Nana M; Agapitos E; Gika A; Drakos SG; Terrovitis JV; Ntalianis A; Nanas JN J Am Coll Cardiol; 2008 Oct; 52(17):1391-8. PubMed ID: 18940529 [TBL] [Abstract][Full Text] [Related]
11. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy. Lee S; Lu R; Müller-Ehmsen J; Schwinger RH; Brixius K Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1134-8. PubMed ID: 20804510 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211 [TBL] [Abstract][Full Text] [Related]
14. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study. Santagata P; Rigo F; Gherardi S; Pratali L; Drozdz J; Varga A; Picano E Int J Cardiol; 2005 Oct; 105(1):46-52. PubMed ID: 16207544 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of echocardiographic findings in patients with coronary triple vessel disease and dilated cardiomyopathy]. Nakamura H; Sawada H; Aizawa T; Watanabe H; Fujii J J Cardiogr; 1985 Sep; 15(3):585-93. PubMed ID: 3837056 [TBL] [Abstract][Full Text] [Related]
16. [Indications and results of orthotopic heart transplantation in coronary heart disease]. Herrmann G; Haverich A; Cremer J; Fieguth HG; Jurmann M; Wahlers T; Borst HG Z Gesamte Inn Med; 1989 Jan; 44(1):6-11. PubMed ID: 2652897 [TBL] [Abstract][Full Text] [Related]
17. [Myocardial catecholamine content in heart failure--I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease]. Regitz V; Sasse S; Bossaller C; Strasser R; Schüler S; Hetzer R; Fleck E Z Kardiol; 1989 Dec; 78(12):751-8. PubMed ID: 2623916 [TBL] [Abstract][Full Text] [Related]
18. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Abraham D; Hofbauer R; Schäfer R; Blumer R; Paulus P; Miksovsky A; Traxler H; Kocher A; Aharinejad S Circ Res; 2000 Oct; 87(8):644-7. PubMed ID: 11029398 [TBL] [Abstract][Full Text] [Related]
19. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691 [TBL] [Abstract][Full Text] [Related]
20. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy. Athanassopoulos P; Balk AH; Vaessen LM; Caliskan K; Takkenberg JJ; Weimar W; Bogers AJ Int J Cardiol; 2009 Jan; 131(2):246-56. PubMed ID: 18243370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]